Skip to main content

Tag: risperidone

June 2010
News

Pharma companies set their sights on autism

by  /  29 June 2010

A decade of research on the biology of autism, combined with a steady rise in diagnoses, has finally piqued the pharmaceutical industry’s interest in developing drugs for the disorder. Preliminary data from one small clinical trial already show positive results, and results from several others are expected early this summer.

1 Comment
May 2010
Opinion

Multiple diagnoses

by  /  6 May 2010

A whopping 95 percent of children with autism have at least three other psychiatric disorders, and 74 percent have five or more, according to a study in the Journal of Autism and Developmental Disorders.

4 Comments
January 2010
News

First drug for autism enters final stage of testing

by  /  28 January 2010

A large clinical trial to test the first drug specifically designed to treat autism is under way at 12 sites across the United States.

6 Comments
December 2009
Opinion

Approving news

by  /  4 December 2009

In the spirit of Thanksgiving, those dealing with autism received some welcome news last week: The U.S. Food and Drug Administration approved Abilify (aripiprazole) as a treatment for autism-related irritability.

0 Comments
October 2009
News

Therapies reverse autism in mouse model

by  /  19 October 2009

New pharmacological and behavioral interventions can reverse characteristics of autism in a mouse model of the disorder, according to unpublished results presented in poster sessions today at the Society for Neuroscience meeting.

0 Comments
November 2008
News

A drug that lasts for days

by  /  19 November 2008

A new slow-release form of the drug risperidone ― an antipsychotic given to people with schizophrenia, autism and other psychiatric conditions ― lasts in the blood days instead of hours, according to research presented today at the Society for Neuroscience meeting.

0 Comments